https://www.selleckchem.com/products/AZD0530.html
Three weeks after completion of rituximab therapy, the patient was started on her first cycle of bortezomib therapy. She received a total of 6 cycles, with improvement in her clinical status beginning with the third cycle. Upon completion of 6 cycles, the patient's mental status and level of functioning had greatly improved. She was discharged to an inpatient rehabilitation facility and ultimately able to return home to her family. A 5-year-old female with anti-NMDA receptor encephalitis was successfully treated with bortezomib after ha